The advantage of high relaxivity contrast agents in brain perfusion

European Radiology, Supplement

Volumn 16, Issue 7, 2006, Pages

  Cotton, Francois ^a,b,c   Hermier, Marc ^b,d  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b UNIVERSITÉ DE LYON   (France)

^c Laboratoire d'Anatomie   (France)

^d HÔPITAL NEUROLOGIQUE   (France)

Author keywords

Brain diseases; Contrast agents; Magnetic resonance imaging; Perfusion imaging

Indexed keywords

GADOBENATE DIMEGLUMINE;

ARTICLE; BRAIN ABSCESS; BRAIN BLOOD VOLUME; BRAIN DISEASE; BRAIN ISCHEMIA; BRAIN PERFUSION; BRAIN TUMOR; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ENCEPHALITIS; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE QUALITY; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITY CONTROL; SAFETY; SENSITIVITY ANALYSIS; SIGNAL DETECTION; STROKE;

BLOOD-BRAIN BARRIER; BRAIN ABSCESS; BRAIN DISEASES; BRAIN INJURIES; BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; MEGLUMINE; ORGANOMETALLIC COMPOUNDS;

EID: 33845406757     PISSN: 16133749     EISSN: 16133757     Source Type: Journal    
DOI: 10.1007/s10406-006-0192-3     Document Type: Article

References (39)

1. Grandin CB, Duprez TP, Smith AM et al (2002) Which MR-derived perfusion parameters are the best predictors of infarct growth in hyperacute stroke? Comparative study between relative and quantitative measurements. Radiology 223:361-370
2. Martel AL, Allder SJ, Delay GS et al (2001) Perfusion MRI of infarcted and noninfarcted brain tissue in stroke: A comparison of conventional hemodynamic imaging and factor analysis of dynamic studies. Invest Radiol 36:378-385
3. Knopp EA, Cha S, Mazumdar A et al (1999) Glial neoplasms: Dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 211:791-798
4. Fuss M, Wenz F, Scholdei R et al (2000) Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: Quantification and time and dose-dependent occurrence. Int J Radiat Oncol Biol Phys 48:53-58
5. Cha S, Knopp EA, Johnson G et al (2002) Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 223:11-29
6. Rollin N, Guyotat J, Streichenberger N et al (2006) Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors. Neuroradiology 48:150-159
7. Ge Y, Law M, Johnson G et al (2005) Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: Characterizing hemodynamic impairment and inflammatory activity. AJNR Am J Neuroradiol 26:1539-1547
8. Rowley HA, Roberts TP (2004) Clinical perspectives in perfusion: neuroradiologic applications. Top Magn Reson Imaging 15:28-40
9. Cavagna FM, Maggioni F, Castelli PM et al (1997) Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 32:780-796
10. de Haën C, Cabrini M, Akhnana L et al (1999) Gadobenate dimeglumine 0.5 M solution for injection (MultiHance) pharmaceutical formulation and physicochemical properties of a new magnetic resonance imaging contrast medium. J Comput Assist Tomogr 23 [Suppl 1]:S161-S168
11. Pintaske J, Martirosian P, Graf H et al (2006) Relaxivity of gadopentetate dimeglumine (Magnevist), gadobutrol (Gadovist) and gadobenate dimeglumine (MultiHance®) in human blood plasma at 0.2 T, 1.5 T and 3 T. Invest Radiol 41:213-221
12. Essig M, Lodemann KP, Le-Huu M et al (2006) Intra-individual comparison of gadobenate dimeglumine and gadobutrol for cerebral MR perfusion imaging at 1.5 T. Invest Radiol 41:256-263
13. Helenius J, Perkio J, Soinne L et al (2003) Cerebral hemodynamics in a healthy population measured by dynamic susceptibility contrast MR imaging. Acta Radiol 44:538-546
14. Ibaraki M, Shimosegawa E, Toyoshima H et al (2005) Effect of regional tracer delay on CBF in healthy subjects measured with dynamic susceptibility contrast-enhanced MRI: Comparison with 15OPET. Magn Reson Med Sci 4:27-34
15. Duyn JH, van Gelderen P, Talagala L et al (2005) Technological advances in MRI measurement of brain perfusion. J Magn Reson Imaging 22:751-753
16. Ginsberg LE, Fuller GN, Hashmi M et al (1998) The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. Surg Neurol 49:436-440
17. Law M, Yang S, Babb JS et al (2004) Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 25:746-755
18. Colosimo C, Ruscalleda J, Korves M et al (2001) Detection of intracranial metastases: A multi-center, intrapatient comparison of gadobenate dimeglumine-enhanced MRI with routinely used contrast agents at equal dose. Invest Radiol 36:72-81
19. Knopp MV, Runge VM, Essig M et al (2004) Primary and secondary brain tumors at MR imaging: Bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Radiology 230:55-64
20. Colosimo C, Knopp MV, Barreau X et al (2004) A comparison of Gd-BOPTA and Gd-DOTA for contrast-enhanced MRI of intracranial tumors. Neuroradiology 46:655-665
21. Maravilla KR, Maldjian JA, Schmalfuss IM et al (2006) Contrast enhancement of central nervous system lesions: Multicenter intraindividual crossover comparative study of two MR contrast agents. Radiology 240:389-400
22. Colosimo C, Demaerel P, Tortori-Donati P et al (2005) Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumors in pediatric subjects. Pediatr Radiol 35:501-510
23. Kremer S, Grand S, Remy C et al (2004) Contribution of dynamic contrast MR imaging to the differentiation between dural metastasis and meningioma. Neuroradiology 46:642-648
24. Ludemann L, Grieger W, Wurm R et al (2005) Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI. Magn Reson Imaging 23:833-841
25. Essig M (2005) Gadobenate dimeglumine (MultiHance) in MR imaging of the CNS: Studies to assess the benefits of a high relaxivity contrast agent. Acad Radiol 12 [Suppl 1]:S23-27
26. Moseley ME, Kucharczyk J, Mintorovitch J et al (1990) Diffusion-weighted MR imaging of acute stroke: Correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats. AJNR Am J Neuroradiol 11:423-429
27. Warach S, Gaa J, Siewert B et al (1995) Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol 37:231-241
28. Guckel FJ, Brix G, Schmiedek P et al (1996) Cerebrovascular reserve capacity in patients with occlusive cerebrovascular disease: Assessment with dynamic susceptibility contrast-enhanced MR imaging and the acetazolamide stimulation test. Radiology 201:405-412
29. Pediconi F, Fraioli F, Catalano C et al (2003) Gadobenate dimeglumine (Gd-BOPTA) vs. gadopentetate dimeglumine (Gd-DTPA) for contrastenhanced magnetic resonance angiography (MRA): Improvement in intravascular signal intensity and contrast to noise ratio. Radiol Med (Torino) 106:87-93
30. Anzalone N, Scomazzoni F, Castellano R et al (2005) Carotid artery stenosis: Intra-individual correlations of unenhanced MR angiography, and digital subtraction angiography versus rotational angiography for detection and grading. Radiology 236:204-213
31. Catalano C, Pediconi F, Nardis P et al (2004) MR angiography with MultiHance for imaging the supraaortic vessels. Eur Radiol 14 [Suppl 7]:O45-51; discussion O61-62
32. Jung HW, Chang KH, Choi DS et al (1995) Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: Optimal dose of gadopentetate dimeglumine. AJR Am J Roentgenol 165:1251-1255
33. Parker DL, Goodrich KC, Alexander AL et al (1998) Optimized visualization of vessels in contrast enhanced intracranial MR angiography. Magn Reson Med 40:873-882
34. Mathews VP, Ulmer JL, White ML et al (1999) Depiction of intracranial vessels with MRA: Utility of magnetization transfer saturation and gadolinium. J Comput Assist Tomogr 23:597-602
35. Ebisu T, Tanaka C, Umeda M et al (1996) Discrimination of brain abscess from necrotic or cystic tumors by diffusion-weighted echo planar imaging. Magn Reson Imaging 14:1113-1116
36. Hakyemez B, Erdogan C, Yildirim N, Parlak M (2005) Glioblastoma multiforme with atypical diffusion-weighted MR findings. Br J Radiol 78:989-992
37. Holmes TM, Petrella JR, Provenzale JM (2004) Distinction between cerebral abscesses and high-grade neoplasms by dynamic susceptibility contrast perfusion MRI. AJR Am J Roentgenol 183:1247-1252
38. Erdogan C, Hakyemez B, Yildirim N, Parlak M (2005) Brain abscess and cystic brain tumor: Discrimination with dynamic susceptibility contrast perfusion-weighted MRI. J Comput Assist Tomogr 29:663-667
39. Ernst TM, Chang L, Witt MD et al (1998) Cerebral toxoplasmosis and lymphoma in AIDS: Perfusion MR imaging experience in 13 patients. Radiology 208:663-669